Studies have shown that patients with decompensated heart failure (HF) have higher LPS concentrations compared to those with stable HF, and the progression of HF is associated with an increase in inflammatory markers such as soluble (s) CD14, tumor necrosis factor (TNF)α, and interleukin 6 (IL-6) (25, 26). The gene discussed is IL6; the disease is heart failure.